Literature DB >> 3803424

Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects.

A Lindberg, Y Bergqvist, L Rombo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803424     DOI: 10.1007/bf00606671

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.

Authors:  J C Cavallito; C A Nichol; W D Brenckman; R L Deangelis; D R Stickney; W S Simmons; C W Sigel
Journal:  Drug Metab Dispos       Date:  1978 May-Jun       Impact factor: 3.922

2.  Comparative toxicological, chemotherapeutic and pharmacokinetic studies with sulphormethoxine and other sulphonamides in animals and man.

Authors:  E Böhni; B Fust; J Rieder; K Schaerer; L Havas
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

3.  Simultaneous determination of pyrimethamine and sulphadoxine in human plasma by high-performance liquid chromatography.

Authors:  Y Bergqvist; M Eriksson
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

  3 in total
  3 in total

1.  Pancytopenia in a patient given pyrimethamine and sulphamethoxidiazine during pregnancy.

Authors:  A Pajor
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

Review 2.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.

Authors:  T Trenque; N Simon; I Villena; C Chemla; C Quereux; B Leroux; R Jaussaud; G Rémy; D Dupouy; H Millart; J-M Pinon; S Urien
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.